Global Genomic Testing In Cancer Market Research Report 2025(Status and Outlook)
Genomic testing in cancer, also known as molecular profiling or tumor genetic testing, involves the comprehensive analysis of a patient?s tumor tissue or blood sample to identify specific genetic mutations, biomarkers, or alterations (such as gene fusions, amplifications, or microsatellite instability) that drive cancer growth, influence prognosis, or determine responsiveness to targeted therapies, immunotherapies, or clinical trials. This precision medicine approach enables clinicians to move beyond traditional cancer classifications based solely on tumor location or histology, instead tailoring treatment strategies to the unique molecular characteristics of an individual?s cancer, thereby optimizing therapeutic efficacy, minimizing unnecessary side effects, and facilitating more personalized patient care.
The global Genomic Testing In Cancer market size was estimated at USD 13250.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 11.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Genomic Testing In Cancer market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Genomic Testing In Cancer market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Genomic Testing In Cancer market.
Global Genomic Testing In Cancer Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
Market Segmentation (by Type)
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Market Segmentation (by Application)
General Hospitals
Specialty Clinics
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genomic Testing In Cancer Market
Overview of the regional outlook of the Genomic Testing In Cancer Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genomic Testing In Cancer Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Genomic Testing In Cancer, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Genomic Testing In Cancer market size was estimated at USD 13250.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 11.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Genomic Testing In Cancer market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Genomic Testing In Cancer market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Genomic Testing In Cancer market.
Global Genomic Testing In Cancer Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
Market Segmentation (by Type)
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Market Segmentation (by Application)
General Hospitals
Specialty Clinics
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genomic Testing In Cancer Market
Overview of the regional outlook of the Genomic Testing In Cancer Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genomic Testing In Cancer Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Genomic Testing In Cancer, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Genomic Testing In Cancer
1.2 Key Market Segments
1.2.1 Genomic Testing In Cancer Segment by Type
1.2.2 Genomic Testing In Cancer Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENOMIC TESTING IN CANCER MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Genomic Testing In Cancer Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Genomic Testing In Cancer Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENOMIC TESTING IN CANCER MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Genomic Testing In Cancer Product Life Cycle
3.3 Global Genomic Testing In Cancer Sales by Manufacturers (2020-2025)
3.4 Global Genomic Testing In Cancer Revenue Market Share by Manufacturers (2020-2025)
3.5 Genomic Testing In Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Genomic Testing In Cancer Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Genomic Testing In Cancer Market Competitive Situation and Trends
3.8.1 Genomic Testing In Cancer Market Concentration Rate
3.8.2 Global 5 and 10 Largest Genomic Testing In Cancer Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENOMIC TESTING IN CANCER INDUSTRY CHAIN ANALYSIS
4.1 Genomic Testing In Cancer Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENOMIC TESTING IN CANCER MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Genomic Testing In Cancer Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Genomic Testing In Cancer Market
5.7 ESG Ratings of Leading Companies
6 GENOMIC TESTING IN CANCER MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genomic Testing In Cancer Sales Market Share by Type (2020-2025)
6.3 Global Genomic Testing In Cancer Market Size Market Share by Type (2020-2025)
6.4 Global Genomic Testing In Cancer Price by Type (2020-2025)
7 GENOMIC TESTING IN CANCER MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genomic Testing In Cancer Market Sales by Application (2020-2025)
7.3 Global Genomic Testing In Cancer Market Size (M USD) by Application (2020-2025)
7.4 Global Genomic Testing In Cancer Sales Growth Rate by Application (2020-2025)
8 GENOMIC TESTING IN CANCER MARKET SALES BY REGION
8.1 Global Genomic Testing In Cancer Sales by Region
8.1.1 Global Genomic Testing In Cancer Sales by Region
8.1.2 Global Genomic Testing In Cancer Sales Market Share by Region
8.2 Global Genomic Testing In Cancer Market Size by Region
8.2.1 Global Genomic Testing In Cancer Market Size by Region
8.2.2 Global Genomic Testing In Cancer Market Size Market Share by Region
8.3 North America
8.3.1 North America Genomic Testing In Cancer Sales by Country
8.3.2 North America Genomic Testing In Cancer Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Genomic Testing In Cancer Sales by Country
8.4.2 Europe Genomic Testing In Cancer Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Genomic Testing In Cancer Sales by Region
8.5.2 Asia Pacific Genomic Testing In Cancer Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Genomic Testing In Cancer Sales by Country
8.6.2 South America Genomic Testing In Cancer Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Genomic Testing In Cancer Sales by Region
8.7.2 Middle East and Africa Genomic Testing In Cancer Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENOMIC TESTING IN CANCER MARKET PRODUCTION BY REGION
9.1 Global Production of Genomic Testing In Cancer by Region(2020-2025)
9.2 Global Genomic Testing In Cancer Revenue Market Share by Region (2020-2025)
9.3 Global Genomic Testing In Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Genomic Testing In Cancer Production
9.4.1 North America Genomic Testing In Cancer Production Growth Rate (2020-2025)
9.4.2 North America Genomic Testing In Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Genomic Testing In Cancer Production
9.5.1 Europe Genomic Testing In Cancer Production Growth Rate (2020-2025)
9.5.2 Europe Genomic Testing In Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Genomic Testing In Cancer Production (2020-2025)
9.6.1 Japan Genomic Testing In Cancer Production Growth Rate (2020-2025)
9.6.2 Japan Genomic Testing In Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Genomic Testing In Cancer Production (2020-2025)
9.7.1 China Genomic Testing In Cancer Production Growth Rate (2020-2025)
9.7.2 China Genomic Testing In Cancer Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 23andMe
10.1.1 23andMe Basic Information
10.1.2 23andMe Genomic Testing In Cancer Product Overview
10.1.3 23andMe Genomic Testing In Cancer Product Market Performance
10.1.4 23andMe Business Overview
10.1.5 23andMe SWOT Analysis
10.1.6 23andMe Recent Developments
10.2 Agilent Technologies
10.2.1 Agilent Technologies Basic Information
10.2.2 Agilent Technologies Genomic Testing In Cancer Product Overview
10.2.3 Agilent Technologies Genomic Testing In Cancer Product Market Performance
10.2.4 Agilent Technologies Business Overview
10.2.5 Agilent Technologies SWOT Analysis
10.2.6 Agilent Technologies Recent Developments
10.3 Bio-Rad Laboratories
10.3.1 Bio-Rad Laboratories Basic Information
10.3.2 Bio-Rad Laboratories Genomic Testing In Cancer Product Overview
10.3.3 Bio-Rad Laboratories Genomic Testing In Cancer Product Market Performance
10.3.4 Bio-Rad Laboratories Business Overview
10.3.5 Bio-Rad Laboratories SWOT Analysis
10.3.6 Bio-Rad Laboratories Recent Developments
10.4 Centogene
10.4.1 Centogene Basic Information
10.4.2 Centogene Genomic Testing In Cancer Product Overview
10.4.3 Centogene Genomic Testing In Cancer Product Market Performance
10.4.4 Centogene Business Overview
10.4.5 Centogene Recent Developments
10.5 Color Genomics
10.5.1 Color Genomics Basic Information
10.5.2 Color Genomics Genomic Testing In Cancer Product Overview
10.5.3 Color Genomics Genomic Testing In Cancer Product Market Performance
10.5.4 Color Genomics Business Overview
10.5.5 Color Genomics Recent Developments
10.6 Gene By Gene
10.6.1 Gene By Gene Basic Information
10.6.2 Gene By Gene Genomic Testing In Cancer Product Overview
10.6.3 Gene By Gene Genomic Testing In Cancer Product Market Performance
10.6.4 Gene By Gene Business Overview
10.6.5 Gene By Gene Recent Developments
10.7 Illumina
10.7.1 Illumina Basic Information
10.7.2 Illumina Genomic Testing In Cancer Product Overview
10.7.3 Illumina Genomic Testing In Cancer Product Market Performance
10.7.4 Illumina Business Overview
10.7.5 Illumina Recent Developments
10.8 LabCorp
10.8.1 LabCorp Basic Information
10.8.2 LabCorp Genomic Testing In Cancer Product Overview
10.8.3 LabCorp Genomic Testing In Cancer Product Market Performance
10.8.4 LabCorp Business Overview
10.8.5 LabCorp Recent Developments
10.9 Myriad Genetics
10.9.1 Myriad Genetics Basic Information
10.9.2 Myriad Genetics Genomic Testing In Cancer Product Overview
10.9.3 Myriad Genetics Genomic Testing In Cancer Product Market Performance
10.9.4 Myriad Genetics Business Overview
10.9.5 Myriad Genetics Recent Developments
10.10 Positive Bioscience
10.10.1 Positive Bioscience Basic Information
10.10.2 Positive Bioscience Genomic Testing In Cancer Product Overview
10.10.3 Positive Bioscience Genomic Testing In Cancer Product Market Performance
10.10.4 Positive Bioscience Business Overview
10.10.5 Positive Bioscience Recent Developments
10.11 Quest Diagnostics
10.11.1 Quest Diagnostics Basic Information
10.11.2 Quest Diagnostics Genomic Testing In Cancer Product Overview
10.11.3 Quest Diagnostics Genomic Testing In Cancer Product Market Performance
10.11.4 Quest Diagnostics Business Overview
10.11.5 Quest Diagnostics Recent Developments
10.12 Thermo Fisher Scientific
10.12.1 Thermo Fisher Scientific Basic Information
10.12.2 Thermo Fisher Scientific Genomic Testing In Cancer Product Overview
10.12.3 Thermo Fisher Scientific Genomic Testing In Cancer Product Market Performance
10.12.4 Thermo Fisher Scientific Business Overview
10.12.5 Thermo Fisher Scientific Recent Developments
11 GENOMIC TESTING IN CANCER MARKET FORECAST BY REGION
11.1 Global Genomic Testing In Cancer Market Size Forecast
11.2 Global Genomic Testing In Cancer Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Genomic Testing In Cancer Market Size Forecast by Country
11.2.3 Asia Pacific Genomic Testing In Cancer Market Size Forecast by Region
11.2.4 South America Genomic Testing In Cancer Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Genomic Testing In Cancer by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Genomic Testing In Cancer Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Genomic Testing In Cancer by Type (2026-2033)
12.1.2 Global Genomic Testing In Cancer Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Genomic Testing In Cancer by Type (2026-2033)
12.2 Global Genomic Testing In Cancer Market Forecast by Application (2026-2033)
12.2.1 Global Genomic Testing In Cancer Sales (K Units) Forecast by Application
12.2.2 Global Genomic Testing In Cancer Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Genomic Testing In Cancer
1.2 Key Market Segments
1.2.1 Genomic Testing In Cancer Segment by Type
1.2.2 Genomic Testing In Cancer Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENOMIC TESTING IN CANCER MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Genomic Testing In Cancer Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Genomic Testing In Cancer Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENOMIC TESTING IN CANCER MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Genomic Testing In Cancer Product Life Cycle
3.3 Global Genomic Testing In Cancer Sales by Manufacturers (2020-2025)
3.4 Global Genomic Testing In Cancer Revenue Market Share by Manufacturers (2020-2025)
3.5 Genomic Testing In Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Genomic Testing In Cancer Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Genomic Testing In Cancer Market Competitive Situation and Trends
3.8.1 Genomic Testing In Cancer Market Concentration Rate
3.8.2 Global 5 and 10 Largest Genomic Testing In Cancer Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENOMIC TESTING IN CANCER INDUSTRY CHAIN ANALYSIS
4.1 Genomic Testing In Cancer Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENOMIC TESTING IN CANCER MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Genomic Testing In Cancer Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Genomic Testing In Cancer Market
5.7 ESG Ratings of Leading Companies
6 GENOMIC TESTING IN CANCER MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genomic Testing In Cancer Sales Market Share by Type (2020-2025)
6.3 Global Genomic Testing In Cancer Market Size Market Share by Type (2020-2025)
6.4 Global Genomic Testing In Cancer Price by Type (2020-2025)
7 GENOMIC TESTING IN CANCER MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genomic Testing In Cancer Market Sales by Application (2020-2025)
7.3 Global Genomic Testing In Cancer Market Size (M USD) by Application (2020-2025)
7.4 Global Genomic Testing In Cancer Sales Growth Rate by Application (2020-2025)
8 GENOMIC TESTING IN CANCER MARKET SALES BY REGION
8.1 Global Genomic Testing In Cancer Sales by Region
8.1.1 Global Genomic Testing In Cancer Sales by Region
8.1.2 Global Genomic Testing In Cancer Sales Market Share by Region
8.2 Global Genomic Testing In Cancer Market Size by Region
8.2.1 Global Genomic Testing In Cancer Market Size by Region
8.2.2 Global Genomic Testing In Cancer Market Size Market Share by Region
8.3 North America
8.3.1 North America Genomic Testing In Cancer Sales by Country
8.3.2 North America Genomic Testing In Cancer Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Genomic Testing In Cancer Sales by Country
8.4.2 Europe Genomic Testing In Cancer Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Genomic Testing In Cancer Sales by Region
8.5.2 Asia Pacific Genomic Testing In Cancer Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Genomic Testing In Cancer Sales by Country
8.6.2 South America Genomic Testing In Cancer Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Genomic Testing In Cancer Sales by Region
8.7.2 Middle East and Africa Genomic Testing In Cancer Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENOMIC TESTING IN CANCER MARKET PRODUCTION BY REGION
9.1 Global Production of Genomic Testing In Cancer by Region(2020-2025)
9.2 Global Genomic Testing In Cancer Revenue Market Share by Region (2020-2025)
9.3 Global Genomic Testing In Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Genomic Testing In Cancer Production
9.4.1 North America Genomic Testing In Cancer Production Growth Rate (2020-2025)
9.4.2 North America Genomic Testing In Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Genomic Testing In Cancer Production
9.5.1 Europe Genomic Testing In Cancer Production Growth Rate (2020-2025)
9.5.2 Europe Genomic Testing In Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Genomic Testing In Cancer Production (2020-2025)
9.6.1 Japan Genomic Testing In Cancer Production Growth Rate (2020-2025)
9.6.2 Japan Genomic Testing In Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Genomic Testing In Cancer Production (2020-2025)
9.7.1 China Genomic Testing In Cancer Production Growth Rate (2020-2025)
9.7.2 China Genomic Testing In Cancer Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 23andMe
10.1.1 23andMe Basic Information
10.1.2 23andMe Genomic Testing In Cancer Product Overview
10.1.3 23andMe Genomic Testing In Cancer Product Market Performance
10.1.4 23andMe Business Overview
10.1.5 23andMe SWOT Analysis
10.1.6 23andMe Recent Developments
10.2 Agilent Technologies
10.2.1 Agilent Technologies Basic Information
10.2.2 Agilent Technologies Genomic Testing In Cancer Product Overview
10.2.3 Agilent Technologies Genomic Testing In Cancer Product Market Performance
10.2.4 Agilent Technologies Business Overview
10.2.5 Agilent Technologies SWOT Analysis
10.2.6 Agilent Technologies Recent Developments
10.3 Bio-Rad Laboratories
10.3.1 Bio-Rad Laboratories Basic Information
10.3.2 Bio-Rad Laboratories Genomic Testing In Cancer Product Overview
10.3.3 Bio-Rad Laboratories Genomic Testing In Cancer Product Market Performance
10.3.4 Bio-Rad Laboratories Business Overview
10.3.5 Bio-Rad Laboratories SWOT Analysis
10.3.6 Bio-Rad Laboratories Recent Developments
10.4 Centogene
10.4.1 Centogene Basic Information
10.4.2 Centogene Genomic Testing In Cancer Product Overview
10.4.3 Centogene Genomic Testing In Cancer Product Market Performance
10.4.4 Centogene Business Overview
10.4.5 Centogene Recent Developments
10.5 Color Genomics
10.5.1 Color Genomics Basic Information
10.5.2 Color Genomics Genomic Testing In Cancer Product Overview
10.5.3 Color Genomics Genomic Testing In Cancer Product Market Performance
10.5.4 Color Genomics Business Overview
10.5.5 Color Genomics Recent Developments
10.6 Gene By Gene
10.6.1 Gene By Gene Basic Information
10.6.2 Gene By Gene Genomic Testing In Cancer Product Overview
10.6.3 Gene By Gene Genomic Testing In Cancer Product Market Performance
10.6.4 Gene By Gene Business Overview
10.6.5 Gene By Gene Recent Developments
10.7 Illumina
10.7.1 Illumina Basic Information
10.7.2 Illumina Genomic Testing In Cancer Product Overview
10.7.3 Illumina Genomic Testing In Cancer Product Market Performance
10.7.4 Illumina Business Overview
10.7.5 Illumina Recent Developments
10.8 LabCorp
10.8.1 LabCorp Basic Information
10.8.2 LabCorp Genomic Testing In Cancer Product Overview
10.8.3 LabCorp Genomic Testing In Cancer Product Market Performance
10.8.4 LabCorp Business Overview
10.8.5 LabCorp Recent Developments
10.9 Myriad Genetics
10.9.1 Myriad Genetics Basic Information
10.9.2 Myriad Genetics Genomic Testing In Cancer Product Overview
10.9.3 Myriad Genetics Genomic Testing In Cancer Product Market Performance
10.9.4 Myriad Genetics Business Overview
10.9.5 Myriad Genetics Recent Developments
10.10 Positive Bioscience
10.10.1 Positive Bioscience Basic Information
10.10.2 Positive Bioscience Genomic Testing In Cancer Product Overview
10.10.3 Positive Bioscience Genomic Testing In Cancer Product Market Performance
10.10.4 Positive Bioscience Business Overview
10.10.5 Positive Bioscience Recent Developments
10.11 Quest Diagnostics
10.11.1 Quest Diagnostics Basic Information
10.11.2 Quest Diagnostics Genomic Testing In Cancer Product Overview
10.11.3 Quest Diagnostics Genomic Testing In Cancer Product Market Performance
10.11.4 Quest Diagnostics Business Overview
10.11.5 Quest Diagnostics Recent Developments
10.12 Thermo Fisher Scientific
10.12.1 Thermo Fisher Scientific Basic Information
10.12.2 Thermo Fisher Scientific Genomic Testing In Cancer Product Overview
10.12.3 Thermo Fisher Scientific Genomic Testing In Cancer Product Market Performance
10.12.4 Thermo Fisher Scientific Business Overview
10.12.5 Thermo Fisher Scientific Recent Developments
11 GENOMIC TESTING IN CANCER MARKET FORECAST BY REGION
11.1 Global Genomic Testing In Cancer Market Size Forecast
11.2 Global Genomic Testing In Cancer Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Genomic Testing In Cancer Market Size Forecast by Country
11.2.3 Asia Pacific Genomic Testing In Cancer Market Size Forecast by Region
11.2.4 South America Genomic Testing In Cancer Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Genomic Testing In Cancer by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Genomic Testing In Cancer Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Genomic Testing In Cancer by Type (2026-2033)
12.1.2 Global Genomic Testing In Cancer Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Genomic Testing In Cancer by Type (2026-2033)
12.2 Global Genomic Testing In Cancer Market Forecast by Application (2026-2033)
12.2.1 Global Genomic Testing In Cancer Sales (K Units) Forecast by Application
12.2.2 Global Genomic Testing In Cancer Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Genomic Testing In Cancer Market Size Comparison by Region (M USD)
Table 5. Global Genomic Testing In Cancer Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Genomic Testing In Cancer Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Genomic Testing In Cancer Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Genomic Testing In Cancer Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Testing In Cancer as of 2024)
Table 10. Global Market Genomic Testing In Cancer Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Genomic Testing In Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Genomic Testing In Cancer Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Genomic Testing In Cancer Sales by Type (K Units)
Table 26. Global Genomic Testing In Cancer Market Size by Type (M USD)
Table 27. Global Genomic Testing In Cancer Sales (K Units) by Type (2020-2025)
Table 28. Global Genomic Testing In Cancer Sales Market Share by Type (2020-2025)
Table 29. Global Genomic Testing In Cancer Market Size (M USD) by Type (2020-2025)
Table 30. Global Genomic Testing In Cancer Market Size Share by Type (2020-2025)
Table 31. Global Genomic Testing In Cancer Price (USD/Unit) by Type (2020-2025)
Table 32. Global Genomic Testing In Cancer Sales (K Units) by Application
Table 33. Global Genomic Testing In Cancer Market Size by Application
Table 34. Global Genomic Testing In Cancer Sales by Application (2020-2025) & (K Units)
Table 35. Global Genomic Testing In Cancer Sales Market Share by Application (2020-2025)
Table 36. Global Genomic Testing In Cancer Market Size by Application (2020-2025) & (M USD)
Table 37. Global Genomic Testing In Cancer Market Share by Application (2020-2025)
Table 38. Global Genomic Testing In Cancer Sales Growth Rate by Application (2020-2025)
Table 39. Global Genomic Testing In Cancer Sales by Region (2020-2025) & (K Units)
Table 40. Global Genomic Testing In Cancer Sales Market Share by Region (2020-2025)
Table 41. Global Genomic Testing In Cancer Market Size by Region (2020-2025) & (M USD)
Table 42. Global Genomic Testing In Cancer Market Size Market Share by Region (2020-2025)
Table 43. North America Genomic Testing In Cancer Sales by Country (2020-2025) & (K Units)
Table 44. North America Genomic Testing In Cancer Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Genomic Testing In Cancer Sales by Country (2020-2025) & (K Units)
Table 46. Europe Genomic Testing In Cancer Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Genomic Testing In Cancer Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Genomic Testing In Cancer Market Size by Region (2020-2025) & (M USD)
Table 49. South America Genomic Testing In Cancer Sales by Country (2020-2025) & (K Units)
Table 50. South America Genomic Testing In Cancer Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Genomic Testing In Cancer Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Genomic Testing In Cancer Market Size by Region (2020-2025) & (M USD)
Table 53. Global Genomic Testing In Cancer Production (K Units) by Region(2020-2025)
Table 54. Global Genomic Testing In Cancer Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Genomic Testing In Cancer Revenue Market Share by Region (2020-2025)
Table 56. Global Genomic Testing In Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Genomic Testing In Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Genomic Testing In Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Genomic Testing In Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Genomic Testing In Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. 23andMe Basic Information
Table 62. 23andMe Genomic Testing In Cancer Product Overview
Table 63. 23andMe Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. 23andMe Business Overview
Table 65. 23andMe SWOT Analysis
Table 66. 23andMe Recent Developments
Table 67. Agilent Technologies Basic Information
Table 68. Agilent Technologies Genomic Testing In Cancer Product Overview
Table 69. Agilent Technologies Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Agilent Technologies Business Overview
Table 71. Agilent Technologies SWOT Analysis
Table 72. Agilent Technologies Recent Developments
Table 73. Bio-Rad Laboratories Basic Information
Table 74. Bio-Rad Laboratories Genomic Testing In Cancer Product Overview
Table 75. Bio-Rad Laboratories Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Bio-Rad Laboratories Business Overview
Table 77. Bio-Rad Laboratories SWOT Analysis
Table 78. Bio-Rad Laboratories Recent Developments
Table 79. Centogene Basic Information
Table 80. Centogene Genomic Testing In Cancer Product Overview
Table 81. Centogene Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Centogene Business Overview
Table 83. Centogene Recent Developments
Table 84. Color Genomics Basic Information
Table 85. Color Genomics Genomic Testing In Cancer Product Overview
Table 86. Color Genomics Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Color Genomics Business Overview
Table 88. Color Genomics Recent Developments
Table 89. Gene By Gene Basic Information
Table 90. Gene By Gene Genomic Testing In Cancer Product Overview
Table 91. Gene By Gene Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Gene By Gene Business Overview
Table 93. Gene By Gene Recent Developments
Table 94. Illumina Basic Information
Table 95. Illumina Genomic Testing In Cancer Product Overview
Table 96. Illumina Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Illumina Business Overview
Table 98. Illumina Recent Developments
Table 99. LabCorp Basic Information
Table 100. LabCorp Genomic Testing In Cancer Product Overview
Table 101. LabCorp Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. LabCorp Business Overview
Table 103. LabCorp Recent Developments
Table 104. Myriad Genetics Basic Information
Table 105. Myriad Genetics Genomic Testing In Cancer Product Overview
Table 106. Myriad Genetics Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Myriad Genetics Business Overview
Table 108. Myriad Genetics Recent Developments
Table 109. Positive Bioscience Basic Information
Table 110. Positive Bioscience Genomic Testing In Cancer Product Overview
Table 111. Positive Bioscience Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Positive Bioscience Business Overview
Table 113. Positive Bioscience Recent Developments
Table 114. Quest Diagnostics Basic Information
Table 115. Quest Diagnostics Genomic Testing In Cancer Product Overview
Table 116. Quest Diagnostics Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Quest Diagnostics Business Overview
Table 118. Quest Diagnostics Recent Developments
Table 119. Thermo Fisher Scientific Basic Information
Table 120. Thermo Fisher Scientific Genomic Testing In Cancer Product Overview
Table 121. Thermo Fisher Scientific Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Thermo Fisher Scientific Business Overview
Table 123. Thermo Fisher Scientific Recent Developments
Table 124. Global Genomic Testing In Cancer Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Global Genomic Testing In Cancer Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Genomic Testing In Cancer Sales Forecast by Country (2026-2033) & (K Units)
Table 127. North America Genomic Testing In Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Genomic Testing In Cancer Sales Forecast by Country (2026-2033) & (K Units)
Table 129. Europe Genomic Testing In Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Genomic Testing In Cancer Sales Forecast by Region (2026-2033) & (K Units)
Table 131. Asia Pacific Genomic Testing In Cancer Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Genomic Testing In Cancer Sales Forecast by Country (2026-2033) & (K Units)
Table 133. South America Genomic Testing In Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Genomic Testing In Cancer Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Genomic Testing In Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Genomic Testing In Cancer Sales Forecast by Type (2026-2033) & (K Units)
Table 137. Global Genomic Testing In Cancer Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Genomic Testing In Cancer Price Forecast by Type (2026-2033) & (USD/Unit)
Table 139. Global Genomic Testing In Cancer Sales (K Units) Forecast by Application (2026-2033)
Table 140. Global Genomic Testing In Cancer Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Genomic Testing In Cancer Market Size Comparison by Region (M USD)
Table 5. Global Genomic Testing In Cancer Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Genomic Testing In Cancer Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Genomic Testing In Cancer Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Genomic Testing In Cancer Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Testing In Cancer as of 2024)
Table 10. Global Market Genomic Testing In Cancer Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Genomic Testing In Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Genomic Testing In Cancer Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Genomic Testing In Cancer Sales by Type (K Units)
Table 26. Global Genomic Testing In Cancer Market Size by Type (M USD)
Table 27. Global Genomic Testing In Cancer Sales (K Units) by Type (2020-2025)
Table 28. Global Genomic Testing In Cancer Sales Market Share by Type (2020-2025)
Table 29. Global Genomic Testing In Cancer Market Size (M USD) by Type (2020-2025)
Table 30. Global Genomic Testing In Cancer Market Size Share by Type (2020-2025)
Table 31. Global Genomic Testing In Cancer Price (USD/Unit) by Type (2020-2025)
Table 32. Global Genomic Testing In Cancer Sales (K Units) by Application
Table 33. Global Genomic Testing In Cancer Market Size by Application
Table 34. Global Genomic Testing In Cancer Sales by Application (2020-2025) & (K Units)
Table 35. Global Genomic Testing In Cancer Sales Market Share by Application (2020-2025)
Table 36. Global Genomic Testing In Cancer Market Size by Application (2020-2025) & (M USD)
Table 37. Global Genomic Testing In Cancer Market Share by Application (2020-2025)
Table 38. Global Genomic Testing In Cancer Sales Growth Rate by Application (2020-2025)
Table 39. Global Genomic Testing In Cancer Sales by Region (2020-2025) & (K Units)
Table 40. Global Genomic Testing In Cancer Sales Market Share by Region (2020-2025)
Table 41. Global Genomic Testing In Cancer Market Size by Region (2020-2025) & (M USD)
Table 42. Global Genomic Testing In Cancer Market Size Market Share by Region (2020-2025)
Table 43. North America Genomic Testing In Cancer Sales by Country (2020-2025) & (K Units)
Table 44. North America Genomic Testing In Cancer Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Genomic Testing In Cancer Sales by Country (2020-2025) & (K Units)
Table 46. Europe Genomic Testing In Cancer Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Genomic Testing In Cancer Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Genomic Testing In Cancer Market Size by Region (2020-2025) & (M USD)
Table 49. South America Genomic Testing In Cancer Sales by Country (2020-2025) & (K Units)
Table 50. South America Genomic Testing In Cancer Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Genomic Testing In Cancer Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Genomic Testing In Cancer Market Size by Region (2020-2025) & (M USD)
Table 53. Global Genomic Testing In Cancer Production (K Units) by Region(2020-2025)
Table 54. Global Genomic Testing In Cancer Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Genomic Testing In Cancer Revenue Market Share by Region (2020-2025)
Table 56. Global Genomic Testing In Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Genomic Testing In Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Genomic Testing In Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Genomic Testing In Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Genomic Testing In Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. 23andMe Basic Information
Table 62. 23andMe Genomic Testing In Cancer Product Overview
Table 63. 23andMe Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. 23andMe Business Overview
Table 65. 23andMe SWOT Analysis
Table 66. 23andMe Recent Developments
Table 67. Agilent Technologies Basic Information
Table 68. Agilent Technologies Genomic Testing In Cancer Product Overview
Table 69. Agilent Technologies Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Agilent Technologies Business Overview
Table 71. Agilent Technologies SWOT Analysis
Table 72. Agilent Technologies Recent Developments
Table 73. Bio-Rad Laboratories Basic Information
Table 74. Bio-Rad Laboratories Genomic Testing In Cancer Product Overview
Table 75. Bio-Rad Laboratories Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Bio-Rad Laboratories Business Overview
Table 77. Bio-Rad Laboratories SWOT Analysis
Table 78. Bio-Rad Laboratories Recent Developments
Table 79. Centogene Basic Information
Table 80. Centogene Genomic Testing In Cancer Product Overview
Table 81. Centogene Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Centogene Business Overview
Table 83. Centogene Recent Developments
Table 84. Color Genomics Basic Information
Table 85. Color Genomics Genomic Testing In Cancer Product Overview
Table 86. Color Genomics Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Color Genomics Business Overview
Table 88. Color Genomics Recent Developments
Table 89. Gene By Gene Basic Information
Table 90. Gene By Gene Genomic Testing In Cancer Product Overview
Table 91. Gene By Gene Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Gene By Gene Business Overview
Table 93. Gene By Gene Recent Developments
Table 94. Illumina Basic Information
Table 95. Illumina Genomic Testing In Cancer Product Overview
Table 96. Illumina Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Illumina Business Overview
Table 98. Illumina Recent Developments
Table 99. LabCorp Basic Information
Table 100. LabCorp Genomic Testing In Cancer Product Overview
Table 101. LabCorp Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. LabCorp Business Overview
Table 103. LabCorp Recent Developments
Table 104. Myriad Genetics Basic Information
Table 105. Myriad Genetics Genomic Testing In Cancer Product Overview
Table 106. Myriad Genetics Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Myriad Genetics Business Overview
Table 108. Myriad Genetics Recent Developments
Table 109. Positive Bioscience Basic Information
Table 110. Positive Bioscience Genomic Testing In Cancer Product Overview
Table 111. Positive Bioscience Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Positive Bioscience Business Overview
Table 113. Positive Bioscience Recent Developments
Table 114. Quest Diagnostics Basic Information
Table 115. Quest Diagnostics Genomic Testing In Cancer Product Overview
Table 116. Quest Diagnostics Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Quest Diagnostics Business Overview
Table 118. Quest Diagnostics Recent Developments
Table 119. Thermo Fisher Scientific Basic Information
Table 120. Thermo Fisher Scientific Genomic Testing In Cancer Product Overview
Table 121. Thermo Fisher Scientific Genomic Testing In Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Thermo Fisher Scientific Business Overview
Table 123. Thermo Fisher Scientific Recent Developments
Table 124. Global Genomic Testing In Cancer Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Global Genomic Testing In Cancer Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Genomic Testing In Cancer Sales Forecast by Country (2026-2033) & (K Units)
Table 127. North America Genomic Testing In Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Genomic Testing In Cancer Sales Forecast by Country (2026-2033) & (K Units)
Table 129. Europe Genomic Testing In Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Genomic Testing In Cancer Sales Forecast by Region (2026-2033) & (K Units)
Table 131. Asia Pacific Genomic Testing In Cancer Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Genomic Testing In Cancer Sales Forecast by Country (2026-2033) & (K Units)
Table 133. South America Genomic Testing In Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Genomic Testing In Cancer Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Genomic Testing In Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Genomic Testing In Cancer Sales Forecast by Type (2026-2033) & (K Units)
Table 137. Global Genomic Testing In Cancer Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Genomic Testing In Cancer Price Forecast by Type (2026-2033) & (USD/Unit)
Table 139. Global Genomic Testing In Cancer Sales (K Units) Forecast by Application (2026-2033)
Table 140. Global Genomic Testing In Cancer Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Genomic Testing In Cancer
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genomic Testing In Cancer Market Size (M USD), 2024-2033
Figure 5. Global Genomic Testing In Cancer Market Size (M USD) (2020-2033)
Figure 6. Global Genomic Testing In Cancer Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Genomic Testing In Cancer Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Genomic Testing In Cancer Product Life Cycle
Figure 13. Genomic Testing In Cancer Sales Share by Manufacturers in 2024
Figure 14. Global Genomic Testing In Cancer Revenue Share by Manufacturers in 2024
Figure 15. Genomic Testing In Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Genomic Testing In Cancer Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Genomic Testing In Cancer Revenue in 2024
Figure 18. Industry Chain Map of Genomic Testing In Cancer
Figure 19. Global Genomic Testing In Cancer Market PEST Analysis
Figure 20. Global Genomic Testing In Cancer Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Genomic Testing In Cancer Market Share by Type
Figure 27. Sales Market Share of Genomic Testing In Cancer by Type (2020-2025)
Figure 28. Sales Market Share of Genomic Testing In Cancer by Type in 2024
Figure 29. Market Size Share of Genomic Testing In Cancer by Type (2020-2025)
Figure 30. Market Size Share of Genomic Testing In Cancer by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Genomic Testing In Cancer Market Share by Application
Figure 33. Global Genomic Testing In Cancer Sales Market Share by Application (2020-2025)
Figure 34. Global Genomic Testing In Cancer Sales Market Share by Application in 2024
Figure 35. Global Genomic Testing In Cancer Market Share by Application (2020-2025)
Figure 36. Global Genomic Testing In Cancer Market Share by Application in 2024
Figure 37. Global Genomic Testing In Cancer Sales Growth Rate by Application (2020-2025)
Figure 38. Global Genomic Testing In Cancer Sales Market Share by Region (2020-2025)
Figure 39. Global Genomic Testing In Cancer Market Size Market Share by Region (2020-2025)
Figure 40. North America Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Genomic Testing In Cancer Sales Market Share by Country in 2024
Figure 43. North America Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Genomic Testing In Cancer Market Size Market Share by Country in 2024
Figure 45. U.S. Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Genomic Testing In Cancer Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Genomic Testing In Cancer Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Genomic Testing In Cancer Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Genomic Testing In Cancer Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Genomic Testing In Cancer Sales Market Share by Country in 2024
Figure 53. Europe Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Genomic Testing In Cancer Market Size Market Share by Country in 2024
Figure 55. Germany Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Genomic Testing In Cancer Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Genomic Testing In Cancer Sales Market Share by Region in 2024
Figure 67. Asia Pacific Genomic Testing In Cancer Market Size Market Share by Region in 2024
Figure 68. China Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Genomic Testing In Cancer Sales and Growth Rate (K Units)
Figure 79. South America Genomic Testing In Cancer Sales Market Share by Country in 2024
Figure 80. South America Genomic Testing In Cancer Market Size and Growth Rate (M USD)
Figure 81. South America Genomic Testing In Cancer Market Size Market Share by Country in 2024
Figure 82. Brazil Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Genomic Testing In Cancer Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Genomic Testing In Cancer Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Genomic Testing In Cancer Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Genomic Testing In Cancer Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Genomic Testing In Cancer Production Market Share by Region (2020-2025)
Figure 103. North America Genomic Testing In Cancer Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Genomic Testing In Cancer Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Genomic Testing In Cancer Production (K Units) Growth Rate (2020-2025)
Figure 106. China Genomic Testing In Cancer Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Genomic Testing In Cancer Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Genomic Testing In Cancer Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Genomic Testing In Cancer Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Genomic Testing In Cancer Market Share Forecast by Type (2026-2033)
Figure 111. Global Genomic Testing In Cancer Sales Forecast by Application (2026-2033)
Figure 112. Global Genomic Testing In Cancer Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Genomic Testing In Cancer
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genomic Testing In Cancer Market Size (M USD), 2024-2033
Figure 5. Global Genomic Testing In Cancer Market Size (M USD) (2020-2033)
Figure 6. Global Genomic Testing In Cancer Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Genomic Testing In Cancer Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Genomic Testing In Cancer Product Life Cycle
Figure 13. Genomic Testing In Cancer Sales Share by Manufacturers in 2024
Figure 14. Global Genomic Testing In Cancer Revenue Share by Manufacturers in 2024
Figure 15. Genomic Testing In Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Genomic Testing In Cancer Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Genomic Testing In Cancer Revenue in 2024
Figure 18. Industry Chain Map of Genomic Testing In Cancer
Figure 19. Global Genomic Testing In Cancer Market PEST Analysis
Figure 20. Global Genomic Testing In Cancer Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Genomic Testing In Cancer Market Share by Type
Figure 27. Sales Market Share of Genomic Testing In Cancer by Type (2020-2025)
Figure 28. Sales Market Share of Genomic Testing In Cancer by Type in 2024
Figure 29. Market Size Share of Genomic Testing In Cancer by Type (2020-2025)
Figure 30. Market Size Share of Genomic Testing In Cancer by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Genomic Testing In Cancer Market Share by Application
Figure 33. Global Genomic Testing In Cancer Sales Market Share by Application (2020-2025)
Figure 34. Global Genomic Testing In Cancer Sales Market Share by Application in 2024
Figure 35. Global Genomic Testing In Cancer Market Share by Application (2020-2025)
Figure 36. Global Genomic Testing In Cancer Market Share by Application in 2024
Figure 37. Global Genomic Testing In Cancer Sales Growth Rate by Application (2020-2025)
Figure 38. Global Genomic Testing In Cancer Sales Market Share by Region (2020-2025)
Figure 39. Global Genomic Testing In Cancer Market Size Market Share by Region (2020-2025)
Figure 40. North America Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Genomic Testing In Cancer Sales Market Share by Country in 2024
Figure 43. North America Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Genomic Testing In Cancer Market Size Market Share by Country in 2024
Figure 45. U.S. Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Genomic Testing In Cancer Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Genomic Testing In Cancer Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Genomic Testing In Cancer Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Genomic Testing In Cancer Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Genomic Testing In Cancer Sales Market Share by Country in 2024
Figure 53. Europe Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Genomic Testing In Cancer Market Size Market Share by Country in 2024
Figure 55. Germany Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Genomic Testing In Cancer Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Genomic Testing In Cancer Sales Market Share by Region in 2024
Figure 67. Asia Pacific Genomic Testing In Cancer Market Size Market Share by Region in 2024
Figure 68. China Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Genomic Testing In Cancer Sales and Growth Rate (K Units)
Figure 79. South America Genomic Testing In Cancer Sales Market Share by Country in 2024
Figure 80. South America Genomic Testing In Cancer Market Size and Growth Rate (M USD)
Figure 81. South America Genomic Testing In Cancer Market Size Market Share by Country in 2024
Figure 82. Brazil Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Genomic Testing In Cancer Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Genomic Testing In Cancer Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Genomic Testing In Cancer Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Genomic Testing In Cancer Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Genomic Testing In Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Genomic Testing In Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Genomic Testing In Cancer Production Market Share by Region (2020-2025)
Figure 103. North America Genomic Testing In Cancer Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Genomic Testing In Cancer Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Genomic Testing In Cancer Production (K Units) Growth Rate (2020-2025)
Figure 106. China Genomic Testing In Cancer Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Genomic Testing In Cancer Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Genomic Testing In Cancer Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Genomic Testing In Cancer Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Genomic Testing In Cancer Market Share Forecast by Type (2026-2033)
Figure 111. Global Genomic Testing In Cancer Sales Forecast by Application (2026-2033)
Figure 112. Global Genomic Testing In Cancer Market Share Forecast by Application (2026-2033)
